❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Translational Cancer Therapy [Flatmark] ❭ News

User participation in our research

 
Apr 24, 2023
Scroll to top

Home Dept. of Tumor Biology Translational Cancer Therapy [Flatmark]

  • Group members
  • From bench to bedside
  • Interventional clinical trials
  • Target discovery in peritoneal surface malignancies
  • Locally advanced and recurrent rectal cancer
  • Experimental treatment
  • Publications
  • News
  • Major collaborators

Recent publications

Officer A, Lindeman I, Pavlovic M, Lund-Andersen C, Ness-Jensen E, Sandve GK, Sollid LM (2026)
Naïve adaptive immune receptor repertoires in celiac disease assessed by machine learning; impact of the HLA-DQ2.5 allotype on the TCR repertoire
Immunogenetics, 78 (1)
DOI 10.1007/s00251-026-01412-3, PubMed 42649420

Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Mark MT, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P et al. (2026)
Editorial Expression of Concern: Tumour exosome integrins determine organotropic metastasis
Nature, 656 (8128), E44
DOI 10.1038/s41586-026-10977-8, PubMed 42557336

Bendix Bräuner K, Bruun B, Bertelsen CA, Johansen Dagenborg V, Safir-Hansen K, Sanko R, Gögenur I, Konge L (2026)
User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study
Acta Oncol, 65, 668-678
DOI 10.2340/1651-226X.2026.45754, PubMed 42535303



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)